As of 2025-05-09, the Fair Value of Telo Genomics Corp (TELO.V) is -0.12 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 CAD, the upside of Telo Genomics Corp is -258.12%.
With the market price of 0.08 CAD and our fair value calculation, Telo Genomics Corp (TELO.V) is not a good investment. Investing in TELO.V stocks now will result in a potential loss of 258.12%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -1.24 | -1.07 | -2.11 | -2.82 | -2.71 | -1.99 |
| YoY growth | -15.59% | 13.83% | -97.25% | -33.66% | 3.82% | -25.77% |
| Market Cap (mil) | 7.50 |
| P/E | |
| Forward P/E |
| EPS | -0.02 |
| Avg earnings growth rate | -25.77% |
| TTM earnings | -2.37 |